BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7705954)

  • 61. Effects of amidated gastrin and glycine-extended gastrin on cell proliferation and crypt fission in parenterally and orally fed rats.
    FitzGerald AJ; Ghatei MA; Mandir N; Bloom SR; Iversen L; Goodlad RA
    Digestion; 2002; 66(1):58-66. PubMed ID: 12379816
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.
    Rocha-Lima CM; de Queiroz Marques Junior E; Bayraktar S; Broome P; Weissman C; Nowacki M; Leslie M; Susnerwala S
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):479-86. PubMed ID: 25030089
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effects of various gastrins on intracellular free Ca2+ in isolated pig parietal cells.
    Cabero JL; Rehfeld JF; MĂ„rdh S
    Acta Physiol Scand; 1989 Jul; 136(3):301-7. PubMed ID: 2750535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunochemical characterization of gastrinlike and cholecystokininlike peptides released in dogs in response to a peptone meal.
    Wolfe MM; McGuigan JE
    Gastroenterology; 1984 Aug; 87(2):323-34. PubMed ID: 6203807
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elimination of porcine heptadecapeptide gastrin (G17) and human leu big gastrin (G34) by the perfused pig liver.
    Feurle GE; Winkler C; Encke A; Helmstaedter V; Doertenbach JG
    Digestion; 1984; 29(3):183-9. PubMed ID: 6745510
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion.
    Smith JP; Shih A; Wu Y; McLaughlin PJ; Zagon IS
    Am J Physiol; 1996 May; 270(5 Pt 2):R1078-84. PubMed ID: 8928909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cellular origins of different forms of gastrin. The specific immunocytochemical localization of related peptides.
    Vaillant C; Dockray G; Hopkins CR
    J Histochem Cytochem; 1979 May; 27(5):932-5. PubMed ID: 90069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bioactivity of analogs of the N-terminal region of gastrin-17.
    Copps J; Ahmed S; Murphy RF; Lovas S
    Peptides; 2009 Dec; 30(12):2263-7. PubMed ID: 19761808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application of anti-sialyl Lea monoclonal antibody, KM231, for immunotherapy of cancer.
    Shitara K; Hanai N; Kusano A; Furuya A; Yoshida H; Wada K; Watanabe T; Sato S
    Anticancer Res; 1991; 11(6):2003-13. PubMed ID: 1776833
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation by gastric acid of the processing of progastrin-derived peptides in rat antral mucosa.
    Macro JA; Bate GW; Varro A; Vaillant C; Seidah NG; Dimaline R; Dockray GJ
    J Physiol; 1997 Jul; 502 ( Pt 2)(Pt 2):409-19. PubMed ID: 9263920
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
    Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
    Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T
    Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
    Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
    Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
    Modjtahedi H; Eccles S; Box G; Styles J; Dean C
    Br J Cancer; 1993 Feb; 67(2):254-61. PubMed ID: 7679281
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathways of processing of the gastrin precursor in rat antral mucosa.
    Varro A; Voronina S; Dockray GJ
    J Clin Invest; 1995 Apr; 95(4):1642-9. PubMed ID: 7706472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Expression of gastrin in human gastric cancer cell line and effect of anti-gastrin mAb on the cell growth].
    Wang X; Wei DP; Cai MY
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):276-8. PubMed ID: 15996318
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transforming growth factor-alpha-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathway.
    Watson SA; Robinson KE; McWilliams D; Michaeli D; Smith AM; Robinson G
    Int J Cancer; 2000 Jul; 87(1):20-8. PubMed ID: 10861448
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells.
    Singh P; Owlia A; Varro A; Dai B; Rajaraman S; Wood T
    Cancer Res; 1996 Sep; 56(18):4111-5. PubMed ID: 8797575
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Binding of CDR-derived peptides is mechanistically different from that of high-affinity parental antibodies.
    Timmerman P; Shochat SG; Desmet J; Barderas R; Casal JI; Meloen RH; Altschuh D
    J Mol Recognit; 2010; 23(6):559-68. PubMed ID: 21038356
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.